Aquestive Therapeutics AQST
NASDAQ AQST
$3.81 -0.02 (-0.52%)
As of: Oct 20, 2026 · 9:38 AM EDT

Aquestive Therapeutics (AQST) Long-Term Debt Issuances (2020)

Updated

Aquestive Therapeutics' Long-Term Debt Issuances came in at $31.14 million for FY2023.

Analysis

Aquestive Therapeutics (AQST) Long-Term Debt Issuances (2020) Analysis & Trends

Going back to FY2017, Aquestive Therapeutics' Long-Term Debt Issuances data covers 4 years.

  • Long-Term Debt Issuances carries a four-year compound annual growth rate of -18.3% (FY2019 to FY2023).
  • The FY2023 figure represents the highest annual Long-Term Debt Issuances since FY2020.
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $50 million in FY2020 (-28.6%) and $70 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,141.50 Bn 1,110.09 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 622.67 Bn 541.20 Bn 17.26 Bn -
3 AbbVie 506.31 Bn 479.43 Bn 12.70 Bn -
4 Merck 365.39 Bn 319.77 Bn 12.21 Bn -
5 Novartis Ag 295.52 Bn 259.51 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 259.13 Bn 232.82 Bn 12.86 Bn -
7 Amgen 231.97 Bn 187.36 Bn 7.24 Bn -
8 Gilead Sciences 193.85 Bn 168.05 Bn 6.22 Bn -
9 Pfizer 170.71 Bn 117.36 Bn 10.94 Bn -
10 Aquestive Therapeutics 476.23 Mn 16.77 Mn 9.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 50.00 Mn
API Access

Aquestive Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=AQST&period=max&api_key=YOUR_API_KEY